Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic
Suzuki et al., Clinical and Experimental Medicine, doi:10.1007/s10238-022-00949-3 (preprint 10/5/2022)
https://c19early.org/suzuki2.html